JUN and cancer: We also found that the pro-angiogenic effect of miR-30d might be due to its regulation on the direct target gene MYPT1, subsequently leading to the activation of c-JUN and the increased expression of VEGFA protein, a critical pro-angiogenic factor secreted by cancer cells.